i need help with #2 #12 #15 #16 #18 #19 #20. im not sure what im doing wrong

f Accounting, Inc. come Statement ling December 31, 2022 Revenues Sales Revenue Cost of Goods Sold Gross Profit Operating Expenses Rent Expense Salary Expense Advertising Expense Repairs \& Maint. Expense Supplies Expense Insurance Expense Depreciation Expense Bad Debt Expense Telephone Expense Total Operating Expenses Income From Operations Before Interest and Income Taxes Interest Expense Net Income Before Tax Income Tax Expense (Round to two decimal places) Net Income After Tax 365 days Annual Cash Dividend Annual Cash Dividend Per Share Cash Flow From Operations Cash+Short-Term Investments+Current Receivables Common Stockholders' Equity Cost of Goods Sold Cost of Goods Sold X 365 Current Assets Current Liabilities Earnings Per Share Ending Inventory Ending Inventory 365 days Gross Profit Income Before Interest Expense and Income Tax Expense Interest Expense Inventory Inventory Turnover Ratio Market Price Per Common Share Net Account Receivables Net Accounts Receivable 365 days Net Credit Sales Net Fixed Assets Net Income Net Income - Preferred Dividends Net Sales Number of Common Shares Outstanding Receivable Turnover Ratio Shares of Common Stock Outstanding Stockholders' Equity Stockholders' Equity Applicable to Common Shares Total Assets Total Equity Total Liabilities f Accounting, Inc. come Statement ling December 31, 2022 Revenues Sales Revenue Cost of Goods Sold Gross Profit Operating Expenses Rent Expense Salary Expense Advertising Expense Repairs \& Maint. Expense Supplies Expense Insurance Expense Depreciation Expense Bad Debt Expense Telephone Expense Total Operating Expenses Income From Operations Before Interest and Income Taxes Interest Expense Net Income Before Tax Income Tax Expense (Round to two decimal places) Net Income After Tax Al the end of the year the markel price of the stock was $35.66 per share. Required: Complete the ratios and the Accounts Recelvable Tumover Acid Test Ratio Basic Earnings Per Share Book Value Per Common Share Current Raso Days' Sales in Imventery Days' Sales Uncellected Debt Rabo Debt To Equify Ratio Oividends Per Share Oividend Yield Fined Asset Turnover Rusio Gross Margin Ratio Inventory Tumover Operating Margin Ratio Price Earnings Ratio Profn Margin Retum on Assets Time Interest Earned Total Asset Tumover Round to two decimat places -Round(number:?) 26.65 904 522 30.7 7.02 0.8 13.7 0.58 137 0.4 0.01 6.11 0.5 455.63 6.95 \begin{tabular}{c|c} 50.01 & 0.0019 \end{tabular} \begin{tabular}{l|l} $23.506.44 \\ \hline 5468.323 .00 & 5.24 \end{tabular} \begin{tabular}{c|l} 3468,32300 & 0.12 \\ \hline$279.26460 \end{tabular} \begin{tabular}{l|l} \$448,323 00 \\ \hline 5228.26460 & 4.57 \end{tabular} \begin{tabular}{c|c} $228.264.60 \\ \hline$328,19666 & 1.37 \end{tabular} f Accounting, Inc. come Statement ling December 31, 2022 Revenues Sales Revenue Cost of Goods Sold Gross Profit Operating Expenses Rent Expense Salary Expense Advertising Expense Repairs \& Maint. Expense Supplies Expense Insurance Expense Depreciation Expense Bad Debt Expense Telephone Expense Total Operating Expenses Income From Operations Before Interest and Income Taxes Interest Expense Net Income Before Tax Income Tax Expense (Round to two decimal places) Net Income After Tax 365 days Annual Cash Dividend Annual Cash Dividend Per Share Cash Flow From Operations Cash+Short-Term Investments+Current Receivables Common Stockholders' Equity Cost of Goods Sold Cost of Goods Sold X 365 Current Assets Current Liabilities Earnings Per Share Ending Inventory Ending Inventory 365 days Gross Profit Income Before Interest Expense and Income Tax Expense Interest Expense Inventory Inventory Turnover Ratio Market Price Per Common Share Net Account Receivables Net Accounts Receivable 365 days Net Credit Sales Net Fixed Assets Net Income Net Income - Preferred Dividends Net Sales Number of Common Shares Outstanding Receivable Turnover Ratio Shares of Common Stock Outstanding Stockholders' Equity Stockholders' Equity Applicable to Common Shares Total Assets Total Equity Total Liabilities f Accounting, Inc. come Statement ling December 31, 2022 Revenues Sales Revenue Cost of Goods Sold Gross Profit Operating Expenses Rent Expense Salary Expense Advertising Expense Repairs \& Maint. Expense Supplies Expense Insurance Expense Depreciation Expense Bad Debt Expense Telephone Expense Total Operating Expenses Income From Operations Before Interest and Income Taxes Interest Expense Net Income Before Tax Income Tax Expense (Round to two decimal places) Net Income After Tax Al the end of the year the markel price of the stock was $35.66 per share. Required: Complete the ratios and the Accounts Recelvable Tumover Acid Test Ratio Basic Earnings Per Share Book Value Per Common Share Current Raso Days' Sales in Imventery Days' Sales Uncellected Debt Rabo Debt To Equify Ratio Oividends Per Share Oividend Yield Fined Asset Turnover Rusio Gross Margin Ratio Inventory Tumover Operating Margin Ratio Price Earnings Ratio Profn Margin Retum on Assets Time Interest Earned Total Asset Tumover Round to two decimat places -Round(number:?) 26.65 904 522 30.7 7.02 0.8 13.7 0.58 137 0.4 0.01 6.11 0.5 455.63 6.95 \begin{tabular}{c|c} 50.01 & 0.0019 \end{tabular} \begin{tabular}{l|l} $23.506.44 \\ \hline 5468.323 .00 & 5.24 \end{tabular} \begin{tabular}{c|l} 3468,32300 & 0.12 \\ \hline$279.26460 \end{tabular} \begin{tabular}{l|l} \$448,323 00 \\ \hline 5228.26460 & 4.57 \end{tabular} \begin{tabular}{c|c} $228.264.60 \\ \hline$328,19666 & 1.37 \end{tabular}